US › Healthcare

Scilex Holding Company (SCLX)

US · Healthcare · Drug Manufacturers - General

$6.47-1.37%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$8.6M
Revenue YoY
+72.1%
Net profit
$-43.3M
Profit YoY
-65.9%
EPS
$-1.17
EPS estimate
$-0.47
Net margin
-502.4%

EPS came in at -1.17 against a street estimate of -0.47 — a miss of 148.9%.

Key statistics

Market cap
$46.9M
Forward P/E
2.7
P/B
28.85
Book value
$-35.44
EPS (TTM)
$-40.50
52-week high
$21.34
52-week low
$2.62
50-day MA
$6.59
200-day MA
$7.06
Beta
1.73

Analyst view

Analysts rate Scilex Holding Company a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $490.00.

Shareholding

Insiders
11.67%
Institutions
13.11%

Largest institutional holders

FundStake
Armistice Capital, LLC4.23%
Vanguard Capital Management, LLC3.75%
BlackRock Inc1.46%
Vanguard Fiduciary Trust Co0.56%
Renaissance Technologies Corp0.52%
State Street Corp0.50%
XTX Topco Ltd0.32%
Northern Trust Corp0.21%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Scilex Holding Company — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.